drugset / Trial / NCT03432156
Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Unknown
68 enrolled
Beijing Friendship Hospital
Newish Technology (Beijing) Co., Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Autologous Tcm cells immunotherapy combining surgery or chemotherapy could effectively prolong survival period and improve quality of life in patients.
Timeline
- Start
- 2018-04-03
- Primary completion
- 2019-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Tcm cells immunotherapy | Cell therapy | — | — |